PriceTargets.com logo

CNSX:RQB - Ravenquest Biomed Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: NaN
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$0.00 As of 05/15/2020 01:00 AM ET
+0.30 (1.20%)
1 month | 3 months | 12 months
Get New Ravenquest Biomed Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for RQB and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for RQB

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$0.00
This price target is based on 0 analysts offering 12 month price targets for Ravenquest Biomed in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a NaN upside from the last price of $0.00.
N/A
The current consensus among 0 contributing investment analysts is to n/a stock in Ravenquest Biomed. This rating has held steady since December 2019, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/7/2019
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/6/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/5/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/3/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/1/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/30/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/29/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/28/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetDetails
12/11/2018Fundamental ResearchBoost Price TargetBuy ➝ Buy$2.05 ➝ $2.09
i
8/8/2018Fundamental ResearchSet Price TargetBuy$2.05
i
4/13/2018Fundamental ResearchSet Price TargetBuy ➝ Buy$2.00
i
3/29/2018Fundamental ResearchInitiated CoverageBuy$2.00
i
(Data available from 2/28/2016 forward)
Ravenquest Biomed logo
RavenQuest BioMed Inc., a cannabis company, focuses on the cannabis production, management services and consulting, and specialized research and development activities. The company operates in two segments, Consulting Business, and Cultivation and Sale of Medical Cannabis. It offers its products under the Lore Cannabis and Bloomera brand names. The company was formerly known as Ravencrest Resources Inc. and changed its name to RavenQuest BioMed Inc. in September 2017. RavenQuest BioMed Inc. was incorporated in 1987 and is based in Vancouver, Canada.
Read More

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

N/A

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Ravenquest Biomed?

The following Wall Street research analysts have issued stock ratings on Ravenquest Biomed in the last year:
View the latest analyst ratings for RQB.

What is the current price target for Ravenquest Biomed?

0 Wall Street analysts have set twelve-month price targets for Ravenquest Biomed in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Ravenquest Biomed in the next year.
View the latest price targets for RQB.

What is the current consensus analyst rating for Ravenquest Biomed?

Ravenquest Biomed currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for RQB.

What other companies compete with Ravenquest Biomed?

Other companies that are similar to Ravenquest Biomed include (THCX.V), 31444, 438280, 815446, Abacus Health Products, Acreage, Althea Group, Applied Biosciences, AusCann Group, Ayr Strategies, Bio-Rad Laboratories, Blueberries Medical, Can B, Cannara Biotech and CannPal Animal Therapeutics.

How do I contact Ravenquest Biomed's investor relations team?

The company's listed phone number is 604-484-1230. The official website for Ravenquest Biomed is www.rqbglobal.com.